LIVE
New today 401
Updated 1,094
New executives 7,938
Reported capital $ 1,426,000
Sign up Log in

MCE PHARMS CONSULTING, INC.

CORPORATION (JOINT-STOCK COMPANY) SUSPENDED No ranking1,007,204 total
RUC: 155680223-2-2019
Total views
141
Avg / month
12
Year peak
24
Current month +41.2 % vs Sep
24

Company information

Folio
155680223 Mercantil
Registration date
28/05/2019
Validity
PERPETUAL
Status
SUSPENDED
Last update
04/09/2023 (hace 2 años)
Request update

Highlights MCE PHARMS CONSULTING, INC.

Currency
US DOLLAR
Share capital
10,000.00
RUC
155680223-2-2019

Executives MCE PHARMS CONSULTING, INC. (6)

Name
Role
Links
View
  • Name JOSE MANUEL RODRIGUEZ Subscriber 167
    Role: Subscriber
    Links: 167
  • Name ALVARO SEGURA FERNÁNDEZ-PIRLA Subscriber 37
    Role: Subscriber
    Links: 37
  • Name FRANCESCO PETER BOSSART Director / President 4
    Role: Director / President
    Links: 4
  • Name FRANCESCO PETER BOSSART Secretary 4
    Role: Secretary
    Links: 4
  • Name FRANCESCO PETER BOSSART Treasurer 4
    Role: Treasurer
    Links: 4
  • Name MICHELLE SACHEZ Director 1
    Role: Director
    Links: 1
  • Name YAURY PEREZ Director 3
    Role: Director
    Links: 3
  • Name FRANCESCO PETER BOSSART Attorney-in-Fact 4
    Role: Attorney-in-Fact
    Links: 4
  • Name EL PRESIDENTE SERÁ EL REPRESENTANTE LEGAL DE LA SOCIEDAD, Y EN SU AUSENCIA EL SECRETARIO Y EN AUSENCIA DEL SECRETARIO EL TESORERO. REPRESENTATIVE - —
    Role: REPRESENTATIVE
    Links: -
    —
*Links: number of companies where the executive appears with a role or relation.

Documents MCE PHARMS CONSULTING, INC. (6)

Act
Date
View
  • Act Electronic Entry Nº 6 (ANNOTATION OF SUSPENSION POR FALTA DE AGENTE RESIDENTE 90 DÍAS) Entry 320076/2023 (0) 03/08/2023
    Date: 03/08/2023
  • Act Electronic Entry Nº 5 (Resident Agent Resignation) Entry 176990/2023 (0) 04/05/2023
    Date: 04/05/2023
  • Act Electronic Entry Nº 4 (CAMBIO DE NOMBRE DE SOCIEDAD O FUNDACIÓN) Entry 88237/2021 (0) 18/03/2021
    Date: 18/03/2021
  • Act Electronic Entry Nº 2 (CHANGE OF DIRECTORS, OFFICERS OR MEMBERS OF COMPANY OR FOUNDATION) Entry 84773/2021 (0) 16/03/2021
    Date: 16/03/2021
  • Act Electronic Entry Nº 3 (PODER GENERAL O ESPECIAL DE SOCIEDAD) Entry 84773/2021 (0) 16/03/2021
    Date: 16/03/2021
  • Act Electronic Entry Nº 1 (Opening of Electronic Folio) Entry 201236/2019 (0) 28/05/2019
    Date: 28/05/2019

Entries / Precedence MCE PHARMS CONSULTING, INC. (5)

Procedure / Document type
Year
View
  • Procedure / Doc. Correction Due to Registry-Attributed Causes 2023
    Year: 2023
  • Procedure / Doc. Renuncia de Directores, Dignatarios y Miembros, Qualification Rights 2023
    Year: 2023
  • Procedure / Doc. Commercial Company Minute, Qualification Rights 2021
    Year: 2021
  • Procedure / Doc. Commercial Company Minute, Qualification Rights 2021
    Year: 2021
  • Procedure / Doc. Incorporation of Company Capital, Single Fee, Qualification Rights 2019
    Year: 2019
Request deletion
About MCE PHARMS CONSULTING, INC.: Summary of MCE PHARMS CONSULTING, INC.: entity CORPORATION (JOINT-STOCK COMPANY), status SUSPENDIDO. Address in District Panamá, Province Panamá. Registered since 28/05/2019. Estimated traffic: 141 total visits (peak 24). Position: no ranking available. See representatives, branches, documents and filings.